Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Anzai

Showing results (191-200 of 193) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 193 results.
Equine Veterinary Journal|May 16, 2001
Molecular surveillance of the incidence of Taylorella equigenitalis and Pseudomonas aeruginosa from horses in Ireland by sequence-specific PCRJ E Moore, T C Buckley, B C Millar, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|January 1, 1994
[Neurocysticercosis with initial clinical picture of acute meningitis]A M Bonametti, J L Baldy, A L Bortoliero, et al.
Memorias Do Instituto Oswaldo Cruz|March 31, 2004
Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. I. Seroconversion rate and adverse effectsJosé Luís da S Baldy, Maria do Carmo M Elisbão, Edson T Anzai, et al.
Pageof 20

Showing results (191-200 of 193) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 193 results.
Equine Veterinary Journal|May 16, 2001
Molecular surveillance of the incidence of Taylorella equigenitalis and Pseudomonas aeruginosa from horses in Ireland by sequence-specific PCRJ E Moore, T C Buckley, B C Millar, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|January 1, 1994
[Neurocysticercosis with initial clinical picture of acute meningitis]A M Bonametti, J L Baldy, A L Bortoliero, et al.
Memorias Do Instituto Oswaldo Cruz|March 31, 2004
Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. I. Seroconversion rate and adverse effectsJosé Luís da S Baldy, Maria do Carmo M Elisbão, Edson T Anzai, et al.
Pageof 20